Sodium-Glucose Transporter 1
"Sodium-Glucose Transporter 1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The founding member of the sodium glucose transport proteins. It is predominately expressed in the INTESTINAL MUCOSA of the SMALL INTESTINE.
Descriptor ID |
D051269
|
MeSH Number(s) |
D12.776.157.530.450.625.437.500 D12.776.157.530.500.750.500 D12.776.157.530.937.696 D12.776.543.585.450.625.562.500 D12.776.543.585.500.750.500 D12.776.543.585.937.821
|
Concept/Terms |
Sodium-Glucose Transporter 1- Sodium-Glucose Transporter 1
- Sodium Glucose Transporter 1
- SLC5A1 Protein
- Sodium-Glucose Cotransporter 1
- Sodium Glucose Cotransporter 1
- SGLT1 Protein
|
Below are MeSH descriptors whose meaning is more general than "Sodium-Glucose Transporter 1".
Below are MeSH descriptors whose meaning is more specific than "Sodium-Glucose Transporter 1".
This graph shows the total number of publications written about "Sodium-Glucose Transporter 1" by people in this website by year, and whether "Sodium-Glucose Transporter 1" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2013 | 1 | 1 | 2 | 2014 | 0 | 1 | 1 | 2017 | 1 | 0 | 1 | 2019 | 1 | 0 | 1 | 2020 | 0 | 3 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Sodium-Glucose Transporter 1" by people in Profiles.
-
Bhatt DL, Szarek M, Steg PG, Cannon CP, Leiter LA, McGuire DK, Lewis JB, Riddle MC, Voors AA, Metra M, Lund LH, Komajda M, Testani JM, Wilcox CS, Ponikowski P, Lopes RD, Verma S, Lapuerta P, Pitt B. Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure. N Engl J Med. 2021 01 14; 384(2):117-128.
-
Bhatt DL, Szarek M, Pitt B, Cannon CP, Leiter LA, McGuire DK, Lewis JB, Riddle MC, Inzucchi SE, Kosiborod MN, Cherney DZI, Dwyer JP, Scirica BM, Bailey CJ, D?az R, Ray KK, Udell JA, Lopes RD, Lapuerta P, Steg PG. Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease. N Engl J Med. 2021 01 14; 384(2):129-139.
-
Vandenbeuch A, Kinnamon SC. Why low concentrations of salt enhance sweet taste. Acta Physiol (Oxf). 2020 12; 230(4):e13560.
-
Srinivasan Sridhar V, Ambinathan JPN, Kretzler M, Pyle LL, Bjornstad P, Eddy S, Cherney DZ, Reich HN. Renal SGLT mRNA expression in human health and disease: a study in two cohorts. Am J Physiol Renal Physiol. 2019 11 01; 317(5):F1224-F1230.
-
Garg SK. Expanding Treatment Options for Improving Health Outcomes in Type 1 Diabetes. Diabetes Technol Ther. 2017 Oct; 19(10):549-551.
-
Choi PM, Sun RC, Sommovilla J, Diaz-Miron J, Khil J, Erwin CR, Guo J, Warner BW. The role of enteral fat as a modulator of body composition after small bowel resection. Surgery. 2014 Aug; 156(2):412-8.
-
Tharabenjasin P, Douard V, Patel C, Krishnamra N, Johnson RJ, Zuo J, Ferraris RP. Acute interactions between intestinal sugar and calcium transport in vitro. Am J Physiol Gastrointest Liver Physiol. 2014 Jan 01; 306(1):G1-12.
-
Garg SK, Michels AW, Shah VN. Use of non-insulin therapies for type 1 diabetes. Diabetes Technol Ther. 2013 Nov; 15(11):901-8.
-
Farrell TL, Ellam SL, Forrelli T, Williamson G. Attenuation of glucose transport across Caco-2 cell monolayers by a polyphenol-rich herbal extract: interactions with SGLT1 and GLUT2 transporters. Biofactors. 2013 Jul-Aug; 39(4):448-56.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|